<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02479984</url>
  </required_header>
  <id_info>
    <org_study_id>NCCCTS-11-555</org_study_id>
    <nct_id>NCT02479984</nct_id>
  </id_info>
  <brief_title>Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer</brief_title>
  <official_title>A Prospective Study Investigating the Role of Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of routine Staging Laparoscopy in patients
      with potentially resectable pancreatobiliary cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the role of routine staging laparoscopy in patients with potentially resectable
      pancreatobiliary cancer. All analyses are performed using SAS version 9.1.3 for Windows (SAS
      institute, Cary, NC). Clinical and pathological variables will be analyzed using the χ2 test
      (or Fisher`s exact test) and the Student`s t test, depending on the normality of the
      distribution. P-values of &lt; 0.05 are considering statistically significant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Probability of diagnosis of metastasis (frequency)</measure>
    <time_frame>baseline</time_frame>
    <description>Probability of diagnosis of metastasis (frequency)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">193</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Staging laparoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resectable pancreatobiliary cancer confirmed by radiologic studies (CT scan, MRI, PET-CT) and no evidence of distant metastasis.
Staging laparoscopy will perform through 2 ports and a 30˚ laparoscope is inserted into the peritoneal cavity. Examining the whole abdominal wall, including the parietal and visceral peritonea, we will observe the liver surface from the dome area to the inferior surface and hepatoduodenal ligament in order to find metastatic nodules. Laparoscopic ultrasound (US) will be used to overcome in inspecting the posterior part of the liver. After complete laparoscopic examination, peritoneal lavage will be performed through the laparoscopic port.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Staging Laparoscopy</intervention_name>
    <description>Resectable pancreatobiliary cancer confirmed by radiologic studies (CT scan, MRI, PET-CT) and no evidence of distant metastasis.
Staging laparoscopy will perform through 2 ports and a 30˚ laparoscope is inserted into the peritoneal cavity. Examining the whole abdominal wall, including the parietal and visceral peritonea, we will observe the liver surface from the dome area to the inferior surface and hepatoduodenal ligament in order to find metastatic nodules. Laparoscopic ultrasound (US) will be used to overcome in inspecting the posterior part of the liver. After complete laparoscopic examination, peritoneal lavage will be performed through the laparoscopic port.</description>
    <arm_group_label>Staging laparoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic ultrasound</intervention_name>
    <arm_group_label>Staging laparoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Resectable pancreatobiliary cancer confirmed by radiologic studies (CT scan, MRI,
             PET-CT)

          2. No evidence of distant metastasis

          3. aged 15-80 year old

          4. performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale

          5. adequate organ functions defined as indicated below

               1. WBC 3000 ~ 12 000/mm3

               2. &gt; Hb 8.0 g/dl

               3. &gt; Plt 100 000/mm3

               4. &lt; Cr 1.2 mg/dl

               5. &gt; Ccr 60 ml/min/body

        Exclusion Criteria:

          1. cystic neoplasm, neuroendocrine tumors

          2. pregnant or breast-feeding women

          3. previous upper abdominal surgery except laparoscopic cholecystectomy 4.Serious illness
             in medical condition

               1. unstable angina or myocardial infarction within 6 months of the trial

               2. unstable hypertension

               3. congestive heart failure

               4. severe respiratory disease requiring continuous oxygen therapy

               5. liver failure

               6. systemic administration of corticosteroids

               7. severe mental disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Jae Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang Jae Park, MD</last_name>
    <phone>82-31-920-1640</phone>
    <email>spark@ncc.re.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Jae Park, MD</last_name>
      <phone>82-31-920-1640</phone>
      <email>spark@ncc.re.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Sang-Jae Park</investigator_full_name>
    <investigator_title>Center for Liver Cancer</investigator_title>
  </responsible_party>
  <keyword>staging laparoscopy</keyword>
  <keyword>pancreatic cancer</keyword>
  <keyword>biliary cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

